| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |